Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis
NCT: NCT04287647 · TERMINATED
Brief Summary
This is a prospective sham study to investigate the role of transpyloric stenting with lumen apposing metal stent (LAMS) as a predictor for clinical response to gastric per-oral endoscopic pyloromyotomy (GPOEM) for refractory gastroparesis. The study hypothesizes that clinical improvement with transpyloric stenting in patients with refractory gastroparesis is a predictor of subsequent clinical success of GPOEM.
Frequently Asked Questions
What is Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis?
Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis is a clinical trial registered under NCT04287647. Current status: TERMINATED.
What is the status of NCT04287647?
The current status of NCT04287647 (Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis) is: TERMINATED.
When did Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis start?
Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis started on 2019-05-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.